A woman from King County, Washington, who was in her late 30’s, has died from a rare blood-clotting syndrome after receiving Johnson & Johnson vaccine on September 7, according to a statement by Public Health – Seattle & King County.
The woman, whose identity was not disclosed, received her vaccination on August 26, 2021. After 11 days of getting the vaccine, she died on September 7 with thrombosis with thrombocytopenia syndrome (TTS).
The CDC verified that the woman indeed died from the vaccine and confirmed the diagnosis.
The Washington State Department of Health released a statement regarding the recent death of the woman:
TRENDING: EXPLOSIVE VIDEO Emerges of Fauci and HHS Officials Plotting for 'A New Avian Flu Virus' to Enforce Universal Flu Vaccination (VIDEO)
More from Aljazeera:
J&J said that the booster shot will increase effectiveness to 94%, given about two months after the first shot. If approve, J&J will be no longer a one-shot vaccine.
The Biden administration previously called on states to ‘pause’ the J&J vaccine after reports of blood clots in women aged 18-48–including one fatality–out of about seven million administered vaccines.
The woman, whose identity was not disclosed, received her vaccination on August 26, 2021. After 11 days of getting the vaccine, she died on September 7 with thrombosis with thrombocytopenia syndrome (TTS).
The CDC verified that the woman indeed died from the vaccine and confirmed the diagnosis.
The Washington State Department of Health released a statement regarding the recent death of the woman:
TRENDING: EXPLOSIVE VIDEO Emerges of Fauci and HHS Officials Plotting for 'A New Avian Flu Virus' to Enforce Universal Flu Vaccination (VIDEO)
A 20-year-old woman in Slovenia suffered the same fate and died two weeks after taking the J&J shot.“Sadly, this is the first such death in Washington State. We send our deepest condolences to her family and loved ones. Losing a loved one at any time is a tragic and difficult and pain that’s become all too familiar in the last year and a half of this pandemic.” says Umair A. Shah, MD, MPH, Secretary of Health.
More from Aljazeera:
Despite the risk of the vaccine, one-shot Johnson & Johnson had submitted an application to the F.D.A for emergency use authorization of a booster shot in people aged 18 and older and is planning to submit data to WHO and to other health agencies.Slovenia has suspended vaccinations with the Johnson & Johnson coronavirus jab while it probes the death of a 20-year-old woman, as thousands gathered to protest against vaccination in the small European Union nation.
The suspension will be in place until experts examine whether there is a link between the woman’s death from a stroke and the vaccine she received two weeks earlier, Health Minister Janez Poklukar said on Wednesday.
J&J said that the booster shot will increase effectiveness to 94%, given about two months after the first shot. If approve, J&J will be no longer a one-shot vaccine.
The Biden administration previously called on states to ‘pause’ the J&J vaccine after reports of blood clots in women aged 18-48–including one fatality–out of about seven million administered vaccines.